Harald zur Hausen, PhD, a German virologist who won the 2008 Nobel Prize in Medicine for his discovery that human papillomavirus caused cervical cancer, died May 29 at 87, The New York Times reported June 9.
Oncology
Oncologist pay and volume is up 13 percent, but 35 percent of oncologists still take extra work, a Medscape survey found.
Miami-based Sylvester Comprehensive Cancer Center researchers found federal cancer research funding is heavily allocated to cancers that occur more often in white people than other racial groups.
The Moores Cancer Center at UC San Diego Health is revamping its clinical trials right as its director is stepping down for personal reasons, the La Jolla Light reported June 7.
Cancer survivors in the United States who report diminished quality of life "more than doubled" in the past two decades, according to a study published May 11 in JAMA Oncology.
Tampa-based Moffitt Cancer Center appointed Xavier Avat as chief business officer, the Business Observer reported June 5.
Continuing immunotherapy treatments when a renal cancer patient's disease has progressed may actually do more harm than good, according to results of a new study from Los Angeles-based City of Hope researchers.
Some patients with locally advanced rectal cancer may be able to safely forgo radiation before surgery to remove tumors, according to research published June 4 in The New England Journal of Medicine and the Journal of Clinical Oncology.
Grail, a company that developed blood tests to detect cancer, mistakenly sent approximately 400 customers letters saying they might be positive for the disease, The New York Times reported June 4.
GenesisCare, a global cancer and cardiac care service provider, has filed for Chapter 11 bankruptcy, according to a June 1 press release.
